Inactive Instrument

Insiders LIDDS AB (publ) Nasdaq Stockholm

Equities

LIDDS AB Announces CEO Changes, Effective 1 September 2024	May. 14	CI
LIDDS AB Approves Board Elections	Jan. 09	CI
Lidds AB Announces Resignation of Daniel Lifveredson from Board of Directors	Dec. 07	CI
Lidds CFO to Take Over CEO Role; Shares Plunge	Nov. 28	MT
LIDDS AB Announces CEO Changes	Nov. 28	CI
LIDDS AB Announces CEO Changes	23-07-31	CI
Max Mitteregger Resigns from the LIDDS's Board	23-07-02	CI
Anders MÃ¥nsson Plans to Leave the LIDDS AB as CEO	23-06-27	CI
LIDDS AB Announces Management Changes	23-03-13	CI
LIDDS AB Announces CEO Changes	22-07-15	CI
LIDDS AB Appoint Executives	22-07-07	CI
LIDDS AB Announces Board Changes	22-06-01	CI
LIDDS Appoints Matthew Lindon as Chief Scientific Officer, Effective March 1, 2022	21-12-20	CI
LIDDS AB Announces Board Changes	21-11-17	CI
LIDDS AB Announces Appointment of Johan Harmenberg as Chief Medical Officer	21-11-15	CI
LIDDS AB Announces Management Changes, Effective April 19, 2021	20-12-15	CI
LIDDS Employs Charlotta Gauffin as Head of Clinical Development	19-02-06	CI
LIDDS Appoints Markus Thor as Head of Business Development and Will Join the in March 2019	19-01-10	CI

No results for this search